Body And Mind CEO Will Discuss Growth Plans And Opening New Dispensaries During COVID Shutdowns

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga.
 
Raising capital and becoming a multi-state operator is no easy feat in the cannabis industry. For the successful minority, a combination of strategic planning, a focus on quality, along with multiple other factors work in tandem towards achieving these milestones.
 
Started in their home market of Nevada, Body and Mind is one such cannabis company that has taken its experience, quality culture, and proven products and expanded its operations to California, Ohio, and Arkansas.
 
CEO of Body and Mind Michael Mills will be joining the upcoming Benzinga Cannabis Capital Conference to discuss the company’s five-year history in award-winning cannabis products and operations and its measured, debt-free approach to growth and building shareholder value. 
 
“Body and Mind is presenting at the Benzinga conference once again because we know this conference consistently brings the top cannabis companies and leaders together in an easily accessible format that enables investors to understand the expanding cannabis industry,” said Mills. 

Continued Expansion

 
At the conference, Mills will be sharing Body and Mind’s lean operations, branded product portfolio, operation expansion, insight behind opening new dispensaries in the middle of COVID shutdowns and the impacts of COVID-19 on the industry.
 
“We’ve been able to expand quickly over the past year with a new production facility and two newly opened dispensaries. We’ve brought our branded product portfolio to California and added production/manufacturing for other national brands,” Mills told Benzinga. “Looking to next year, we’re in the process of developing our production/manufacturing facility in Ohio, starting our cultivation in Arkansas and expanding our portfolio of branded products into these markets.” 
 
Body and Mind is also reviewing numerous accretive acquisition opportunities which would allow for further expansion.

Industry Acceptance

Cannabis capital markets have undergone several waves since the industry first began and investors are now differentiating between operators in specific countries and even specific states 

“Cannabis sales continue to increase and more states are anticipated to license both medical and recreational cannabis products,” said Mills. “Attitudes around cannabis continue to move towards greater acceptance and the broad designation of cannabis as an essential service during COVID shutdowns opened many eyes to the fact that cannabis is a viable, accepted, and growing industry.”

Mills continued on to say that, “As the stigma of cannabis diminishes and well-run U.S. cannabis companies and MSO’s post strong results, there is an opportunity for investors to evaluate which companies will benefit from the significant growth of legal medical and adult-use cannabis.”

To learn more about Body and Mind and expansion in the cannabis industry, you can sign up for the Benzinga Cannabis Capital Conference by clicking here.

Photo by Next Green Wave on Unsplash

The preceding post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Although the piece is not and should not be construed as editorial content, the sponsored content team works to ensure that any and all information contained within is true and accurate to the best of their knowledge and research. This content is for informational purposes only and not intended to be investing advice.